HCM
MED icon

Harspring Capital Management’s Medifast MED Stock Holding History

Harspring Capital Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-24,000
Closed -$2.63M – 30
2019
Q4 		$2.63M Buy
+24,000
New +$2.32M 1.7% 18

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Harspring Capital Management's MED Position: Q1 2020 in Review

Harspring Capital Management sold out of Medifast (MED) in Q1 2020, closing a stake of 24,000 shares — an estimated $2.63M sold.

Harspring Capital Management first reported a position in MED in Q4 2019 and held it in 1 quarter. The position peaked at $2.63M in Q4 2019. 201 funds tracked by Wall St. Rank hold MED as of Q1 2020.

  • Harspring Capital Management reported no remaining Medifast position as of Q1 2020 after selling out during the quarter.
  • Harspring Capital Management sold 24,000 Medifast shares in Q1 2020, an estimated $2.63M.
  • Harspring Capital Management first reported a position in Medifast in Q4 2019 and held it in 1 quarter.
  • Harspring Capital Management's Medifast position peaked at $2.63M in Q4 2019.
  • 201 funds tracked by Wall St. Rank held Medifast as of Q1 2020.

Based on Harspring Capital Management's 13F filing for Q1 2020, filed 12 May 2020.